ESC 365 - Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.

ESC Premium Access

Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.

Session: How to Assess Cardiovascular Risk in Clinical Practice?

Topic: Cardiovascular Risk Assessment

Event: ESC Asia with APSC & AFC

Congress Presentation

Add to my library

5 more presentations in this session

Risk Scores: Advantages and Pitfalls.

Speaker: Professor S. Gielen (Detmold, DE)

Discussion - Risk Scores: Advantages and Pitfalls

Biomarkers in Risk Assessment: Lipids and Beyond.

Speaker: Doctor A. Fong (Kuching, MY)

Imaging – A Must or an Add-on in Risk Assessment?

Speaker: Professor M. Marwan (Erlangen, DE)

Discussion - Imaging – A Must or an Add-on in Risk Assessment?

Access the full session

How to Assess Cardiovascular Risk in Clinical Practice?

Speakers: Professor S. Gielen, Doctor A. Fong, Professor M. Marwan

About the event

ESC Asia with APSC & AFC

8 November - 10 November 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources